Article Data

  • Views 923
  • Dowloads 164

Original Research

Open Access

Dezocine inhibits proliferation as well as migration of endometrial carcinoma in vitro

  • Lu Liu1
  • Bin Qian1,*,
  • Yan Li2
  • Xinglin Zhou1

1Department of Anesthesiology, Yancheng First People’s Hospital, 224006 Yancheng, Jiangsu, China

2Department of Gynecology, Yancheng First People’s Hospital, 224006 Yancheng, Jiangsu, China

DOI: 10.22514/ejgo.2023.081 Vol.44,Issue 5,October 2023 pp.75-82

Submitted: 29 May 2023 Accepted: 20 July 2023

Published: 15 October 2023

*Corresponding Author(s): Bin Qian E-mail: Qianbin_668@163.com

Abstract

Endometrial cancer (EC) includes several epithelial malignancies existed in the endometrium tissues. To improve the prognosis of EC, it is greatly needed to find new drugs. Dezocine, a organic compound, is an κ agonist and a µ receptor antagonist, is used in clinical anesthesia after cancer surgery with few side effects, and its anti-tumor effects have also been demonstrated in several tumors. However, the effects of Dezocine on EC progression have not been elusidated. Herein, we investigated the role of Dezocine in EC cell functions. Through a series of cellular assays, such as cell counting kit-8 (CCK-8), flow cytometry (FCM), transwell assays, we found that Dezocine suppressed the EC cell proliferation, and stimulated EC cell apoptosis in vitro. Furthermore, results revealed Dezocine restrained the motility, including migration and invasion of EC cells. Mechanically, Dezocine suppressed the Akt (protein kinase B, PKB)/mammalian target of rapamycin (mTOR) pathway in EC cells, thereby suppressing EC cell proliferation as well as migration in vitro. In conclusion, Dezocine inhibits proliferation as well as migration of EC in vitro.


Keywords

Endometrial cancer (EC); Dezocine; Apoptosis; Proliferation; Akt/mTOR pathway


Cite and Share

Lu Liu,Bin Qian,Yan Li,Xinglin Zhou. Dezocine inhibits proliferation as well as migration of endometrial carcinoma in vitro. European Journal of Gynaecological Oncology. 2023. 44(5);75-82.

References

[1] AN HJ, SONG DH, KIM Y, JO HC, BAEK JC, PARK JE. Significance of HER2 and VEGFR2 in early-stage endometrial cancer. In Vivo. 2022; 36: 723–730.

[2] Español P, Luna R, Soler C, Caruana P, Altés-Arranz A, Rodríguez F, et al. Neural plasticity of the uterus: new targets for endometrial cancer? Women’s Health. 2022; 18: 17455057221095537.

[3] Goel P, Singh V, Sharma R, Chaudhary D, Chatterjee A, Dora T, et al. Early endometrial carcinoma: experience and outcomes. Journal of Cancer Research and Therapeutics. 2023; 19: S318–S322.

[4] Camilloni A, Nati G, Maggiolini P, Romanelli A, Latina R, Giannarelli D, et al. Chronic non-cancer pain in primary care: an Italian cross-sectional study. Signa Vitae. 2021; 17: 54–62.

[5] Pitakkarnkul S, Chanpanitkitchot S, Tangjitgamol S. Management of inoperable endometrial cancer. Obstetrics & Gynecology Science. 2022; 65: 303–316.

[6] Qiu J, Zhang Y, Xie M. Chrysotoxine attenuates sevoflurane-induced neurotoxicity in vitro via regulating PI3K/AKT/GSK pathway. Signa Vitae. 2021; 17: 185–191.

[7] Tan H, Wang C, Jiang Y, Shi Q, Liang W, Li D. Postoperative effect of sufentanil preemptive analgesia combined with psychological intervention on breast cancer patients. BMC Anesthesiology. 2023; 23: 170.

[8] Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Annals of Surgical Oncology. 2015; 22: 1341–1348.

[9] Zhang C, Pan R, Ma S, Xu S, Wang B. Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer. Open Medicine. 2022; 17: 2052–2061.

[10] Wang H, Chiang C, Xue C, Zhou L, Li S, Zhou Y, et al. Dezocine induces apoptosis in human cervical carcinoma Hela cells via the endoplasmic reticulum stress pathway. Toxicology Research. 2022; 11: 498–510.

[11] Li J, Zhang C, Jiang H, Cheng J. Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth. OncoTargets and Therapy. 2015; 8: 427–435.

[12] Saldaña-Inda I, Tejada-Meza H, Sainz-Pardo A, Moreno-Loscertales C, Marta-Moreno J. Endovascular treatment for acute basilar artery occlusion: descriptive analysis of the experience in a comprehensive stroke centre. Signa Vitae. 2021; 17: 125–131.

[13] Li N, Yang F, Liu D, Guo J, Ge N, Sun S. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway. World Journal of Gastrointestinal Oncology. 2021; 13: 1164–1183.

[14] Ma D, Wu L, Li S, Sun Z, Wang K. Vasohibin2 promotes adriamycin resistance of breast cancer cells through regulating ABCG2 via AKT signaling pathway. Molecular Medicine Reports. 2017; 16: 9729–9734.

[15] Yang Y, Luan Y, Yuan RX, Luan Y. Histone methylation related therapeutic challenge in cardiovascular diseases. Frontiers in Cardiovascular Medicine. 2021; 8: 710053.

[16] Wang L, Cheng L, Ma L, Ahmad Farooqi A, Qiao G, Zhang Y, et al. Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis. Phytotherapy Research. 2022; 36: 525–542.

[17] Redondo A, Gallego A, Mendiola M. Dostarlimab for the treatment of advanced endometrial cancer. Expert Review of Clinical Pharmacology. 2022; 15: 1–9.

[18] Zhang X, Chu C, Ma C, Sun J, Liu Z. Analgesic effect of dizocine combined with ropivacaine on recurrent neuropathic pain in peripheral nerve compression rats. Pharmacology. 2020; 105: 514–521.

[19] Guo Z, Chen P. Physical compatibility and chemical stability of dezocine and ramosetron in 0.9% sodium chloride injection for patient-controlled analgesia administration. Medicine. 2022; 101: e31546.

[20] Huang L, Yan X, Yi M. Hypertensive crisis merging with paroxysmal supraventricular tachycardia after dezocine injection during cesarean delivery: a case report. SAGE Open Medical Case Reports. 2023; 11: 2050313X231160980.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top